Mast cell activation syndrome (MCAS) affects more than 15% of the U.S. population but evades most practitioners’ radar. Just five years ago, it wasn’t even on my radar, despite already having 20 years of experience as a clinician at that time. The more I dug (similar to leaky gut and post-COVID syndrome), the more I found my patients were suffering from this disorder.
Lisa Conboy, MA, MS, ScD
Lisa Conboy has conducted health research and taught research methodology to students of sociology, biomedicine and complementary medicine for over 30 years. With degrees in public health and sociology, she specializes in the study of traditional and complex health systems. She is published in the areas of women’s health, complementary and alternative kedicine, qualitative research methodology, and complexity science. An Instructor at Beth Israel Deaconess Medical Center, Harvard Medical School, she is also the Director of Research and Special Projects at Seattle Institute of East Asian Medicine.; and chair of the Research Committee of the American Society of Acupuncturists.